EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Immune Signatures Associated with Latent TB Infection in PLHIV—Insights from an Integrative Prospective Immune Monitoring Study

Shilpa Bhowmick, Pratik Devadiga, Sapna Yadav, Nandan Mohite, Pranay Gurav iD, Tejaswini Pandey, Varsha Padwal, Namrata Neman, Aarya Suryawanshi, Satyajit Musale, Amit Kumar Singh iD, Sharad Bhagat und 15 weitere

Cells · 17.10.2025 · 14 (20) · 1622

DOI: 10.3390/cells14201622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 17.10.2025. Verfasst von Shilpa Bhowmick und 26 weiteren Autor:innen. Beteiligte Einrichtung: Viral Immunopathogenesis Lab, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India. Hauptthemen laut MEDLINE: Latent Tuberculosis, HIV Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indo-US (ICMR-NIH), DBT-Welcome Trust India Alliance, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding how HIV-1 pathogenesis affects systemic and TB specific immunity in the setting of latent (LTBI+) compared to active TB infection could provide actionable insights for the prevention of reactivation. Fifty HIV-seronegative and 112 HIV-1-positive anti-retroviral therapy (ART)-naïve participants were stratified as LTBI+ (n = 35), active TB+ (n = 22) and non-coinfected (n = 55) based on an interferon gamma release assay (IGRA) and clinical confirmation prior to receiving TB therapy. Systemic and TB-specific (DosR and Rpf) immune monitoring of cellular subsets, together with multi-analyte plasma analysis, was carried out. Pursuant to isoniazid prophylaxis therapy (IPT) and ART initiation, HIV-1-positive LTBI+ participants (HLTBI+) were followed for up to two years. Before ART initiation, HLTBI+ individuals exhibited the lowest levels of circulating intermediate monocytes, T-cell activation and PD-1 expression, with a decreased frequency of T-regulatory cells and higher circulating IL-10 and IL-17A. PD-1 expression on CD4+ T cell memory subsets, together with opposing anamnestic TNF-α responses to DosR and Rpf, was a discriminatory signature for the HLTBI+ group, as was preserved (following ART) TB-specific TNF-α production, which positively correlated with the CD4/CD8 ratio. Our results highlight an immunomodulatory phenotype conferred by latent TB infection in PLHIV, whose preservation may provide strategies to mitigate TB reactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Latent TuberculosisHIV InfectionsHumansMaleFemaleAdultProspective StudiesMonitoring, ImmunologicMiddle AgedHIV-1IsoniazidCD4-Positive T-LymphocytesCoinfection

Stichwörter der Autor:innen

DosR/RpfHIV pathogenesisHIV-TB coinfectionLTBIPD-1 expressionT-cell activationcytokinesflow cytometryintracellular cytokine staining assayregulatory T cells

Substanzen

Isoniazid

Autor:innen und Institutionen

  • Viral Immunopathogenesis Lab, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.
  • Department of Molecular Immunology and Microbiology, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.
  • Department of Child Health research, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.
  • Biomedical Informatics Centre, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.
  • Department of Medicine, Grant Medical College and JJ Group of Hospitals, Mumbai 400008, India.
  • Department of Microbiology, TN Medical College and BYL Nair Hospital, Mumbai 400008, India.

ORCID-Profile: Pranay Gurav, Amit Kumar Singh, Harsha Palav, Shantanu Birje, Vikrant M Bhor, Taruna Madan

Förderung

  • Indo-US (ICMR-NIH)
  • DBT-Welcome Trust India Alliance
  • Indian Council of Medical Research
  • DBT

Zitieren

APA

Bhowmick, S., Devadiga, P., Yadav, S., Mohite, N., Gurav, P., Pandey, T., Padwal, V., Neman, N., Suryawanshi, A., Musale, S., Singh, A. K., Bhagat, S., Kaginkar, S., Palav, H., Birje, S., Kerkar, S., Idicula-Thomas, S., Nagar, V., Patil, P., …, & Patel, V. (2025). Protective Immune Signatures Associated with Latent TB Infection in PLHIV—Insights from an Integrative Prospective Immune Monitoring Study. Cells, 14(20), 1622. https://doi.org/10.3390/cells14201622

Vancouver

Bhowmick S, Devadiga P, Yadav S, Mohite N, Gurav P, Pandey T, et al. Protective Immune Signatures Associated with Latent TB Infection in PLHIV—Insights from an Integrative Prospective Immune Monitoring Study. Cells. 2025;14(20):1622. doi:10.3390/cells14201622

BibTeX
@article{Bhowmick2025,
  author = {Bhowmick, Shilpa and Devadiga, Pratik and Yadav, Sapna and Mohite, Nandan and Gurav, Pranay and Pandey, Tejaswini and Padwal, Varsha and Neman, Namrata and Suryawanshi, Aarya and Musale, Satyajit and Singh, Amit Kumar and Bhagat, Sharad and Kaginkar, Snehal and Palav, Harsha and Birje, Shantanu and Kerkar, Shilpa and Idicula-Thomas, Susan and Nagar, Vidya and Patil, Priya and Agrawal, Sachee and Gaikwad, Sushma and Shastri, Jayanthi and Mukherjee, Nupur and Munne, Kiran and Bhor, Vikrant M and Madan, Taruna and Patel, Vainav},
  title = {Protective Immune Signatures Associated with Latent TB Infection in PLHIV—Insights from an Integrative Prospective Immune Monitoring Study},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {20},
  pages = {1622},
  doi = {10.3390/cells14201622}
}
Kostenlos starten →